Saint Luke's Hospital Investigational Pharmacy — Kansas City, Missouri

Saint Luke's Hospital Investigational Pharmacy is a clinical research site located in Kansas City, Missouri, United States 64111.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Saint Luke's Hospital Investigational Pharmacy has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Saint Luke's Hospital Investigational Pharmacy?

Saint Luke's Hospital Investigational Pharmacy has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Saint Luke's Hospital Investigational Pharmacy conducted?

Saint Luke's Hospital Investigational Pharmacy has 2 clinical trials on record, with 2 currently active. Their work covers HER2-positive Breast Cancer, Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma.

Is Saint Luke's Hospital Investigational Pharmacy accredited by Crixeo Health?

Saint Luke's Hospital Investigational Pharmacy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Saint Luke's Hospital Investigational Pharmacy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.